<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id><journal-id journal-id-type="pmc">bsr</journal-id><journal-id journal-id-type="publisher-id">BSR</journal-id><journal-title-group><journal-title>Bioscience Reports</journal-title></journal-title-group><issn pub-type="ppub">0144-8463</issn><issn pub-type="epub">1573-4935</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">e00155</article-id><article-id pub-id-type="doi">10.1042/BSR20140094</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>NMR structure of the water soluble A&#x003b2;<sub>17&#x02013;34</sub> peptide</article-title><alt-title alt-title-type="right-running-head">A&#x003b2;<sub>17&#x02013;34</sub> NMR structure</alt-title><alt-title alt-title-type="left-running-head">G. Fonar and A.O. Samson</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fonar</surname><given-names>Genadiy</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Samson</surname><given-names>Abraham&#x000a0;O.</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="corresp" rid="COR1"><sup>1</sup></xref></contrib><aff id="A1">*Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 14300, Israel</aff></contrib-group><author-notes><corresp id="COR1"><sup>1</sup>To whom correspondence should be addressed (email <email>avraham.samson@biu.ac.il</email>).</corresp><fn><p>The atomic coordinates of the energy-minimized average coordinates of the A&#x003b2;<sub>17&#x02013;34</sub> have been deposited in the Protein Data Bank under PDB ID 2MJ1, and the proton chemical shifts and J-coupling data have been deposited in the Biological Magnetic Resonance Data Bank under BMRB ID 19701.</p></fn></author-notes><pub-date pub-type="epreprint"><day>6</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>34</volume><issue>6</issue><elocation-id>e00155</elocation-id><history><date date-type="received"><day>24</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Alzheimer's disease is the most common neurodegenerative disorder in the world. Its most significant symptoms are memory loss and decrease in cognition. Alzheimer's disease is characterized by aggregation of two proteins in the brain namely A&#x003b2; (amyloid &#x003b2;) and tau. Recent evidence suggests that the interaction of soluble A&#x003b2; with nAChR (nicotinic acetylcholine receptors) contributes to disease progression. In this study, we determine the NMR structure of an A&#x003b2;<sub>17&#x02013;34</sub> peptide solubilized by the addition of two glutamic acids at each terminus. Our results indicate that the A&#x003b2; peptide adopts an &#x003b1;-helical structure for residues 19&#x02013;26 and 28&#x02013;33. The &#x003b1;-helical structure is broken around residues S26, N27 and K28, which form a kink in the helical conformation. This &#x003b1;-helix was not described earlier in an aqueous solution without organic solvents, and at physiological conditions (pH&#x000a0;7). These data are in agreement with A&#x003b2; adopting an &#x003b1;-helical conformation in the membrane before polymerizing into amyloid &#x003b2;-sheets and provide insight into the intermediate state of A&#x003b2; in Alzheimer's disease.</p></abstract><kwd-group kwd-group-type="kwd"><kwd>Alzheimer&#x02019;s disease</kwd><kwd>amyloid beta</kwd><kwd>amyloid &#x003b2;</kwd><kwd>A&#x003b2;17&#x02013;34</kwd><kwd>NMR</kwd><kwd>soluble peptide</kwd></kwd-group><kwd-group kwd-group-type="abbr"><kwd>A&#x003b2;, amyloid &#x003b2;</kwd><kwd>AChR, acetylcholine receptor</kwd><kwd>APP, amyloid precursor protein</kwd><kwd>HFIP, hexafluoroisopropanol</kwd><kwd>nAChR, nicotinic acetylcholine</kwd><kwd>TFE, trifluoroethanol receptor</kwd></kwd-group><counts><fig-count count="4"/><table-count count="2"/><ref-count count="37"/><page-count count="6"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Alzheimer's disease is widely characterized by amyloid peptide deposits inside brain tissues [<xref rid="B1" ref-type="bibr">1</xref>]. These deposits, also called amyloid plaques, present one of the most characteristic feature of the disease and can be seen in different brain regions [<xref rid="B2" ref-type="bibr">2</xref>]. Amyloid plaques consist of A&#x003b2; (amyloid &#x003b2;) peptides that become aggregated [<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>]. The secondary structure of aggregated A&#x003b2; is mostly &#x003b2;-sheet [<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>] and results from enzymatic cleavage of the APP (amyloid precursor protein) [<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>] by &#x003b1;, &#x003b2; and &#x003b3;-secretases [<xref rid="B11" ref-type="bibr">11</xref>]). When APP is cleaved by &#x003b1;-secretase, the resulting product is a protein named soluble APP&#x003b1;, while cleavage with the two other enzymes, &#x003b2; and &#x003b3;-secretases, results in the creation of a 40 or a 42 amino acids long peptide&#x02013;namely A&#x003b2; [<xref rid="B11" ref-type="bibr">11</xref>]. Mutations in any one of the secretases leads to increased production of A&#x003b2;, and a higher susceptibility for Alzheimer's disease [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>Current structure determination techniques include NMR, X-ray crystallography and cryo-EM (cryoelectron microscopy). Although X-ray crystallography is the most accurate technique for determining the structure of large proteins, NMR is considered more suitable for elucidating the structure of short peptides at physiological conditions [<xref rid="B13" ref-type="bibr">13</xref>]. Several studies have attempted to determine the structure of the A&#x003b2; peptide using NMR, but disconcertingly most of them had to use hydrophobic solvents such as TFE (trifluoroethanol) [<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>] and HFIP (hexafluoroisopropanol) [<xref rid="B17" ref-type="bibr">17</xref>] to increase solubility. Adding TFE and HFIP to A&#x003b2; can induce conformational changes and impose an artificial &#x003b1;-helical structure [<xref rid="B18" ref-type="bibr">18</xref>], thus providing the researchers with biased structural information. Remarkably, one attempt to determine the NMR structure without TFE at physiological conditions, revealed A&#x003b2; to adopt a 3<sub>10</sub>-helical structure incongruent with previous &#x003b1;-helical observations [<xref rid="B19" ref-type="bibr">19</xref>]. Finally, another NMR study used micelles to determine the structure of A&#x003b2;<sub>10&#x02013;35</sub> and found it to possess two &#x003b1;-helical regions within residues 13&#x02013;23 and 30&#x02013;35 [<xref rid="B20" ref-type="bibr">20</xref>].</p><p>In this study, we determine the structure of a soluble A&#x003b2; peptide corresponding to residues 17&#x02013;34 which comprises the nucleation site of A&#x003b2; using NMR spectroscopy at physiological conditions. We find it to adopt a partial &#x003b1;-helical conformation in agreement with bioinformatic secondary structure predictions. This finding sheds light on the A&#x003b2; conformations in Alzheimer's disease and provides a snapshot of the intermediate structure prior to conversion into amyloid plaques.</p></sec><sec><title>EXPERIMENTAL</title><sec><title>A&#x003b2; peptides</title><p>A&#x003b2; peptides corresponding to residues 17&#x02013;34 were purchased and purified by the purveyor to a purity level of &#x0003e;99.9%, using HPLC. These peptides contained two glutamate or arginine residues at the N- and C-termini for increased solubility. The full amino acid sequence of the purchased A&#x003b2; was EELVFFAEDVGSNKGAIIGLEE (Peptide 2.0 Inc. Company) and RRLVFFAEDVGSNKGAIIGLRR (Sigma-Aldrich). The peptide mass was verified using MALDI-TOF mass spectroscopy. To dissolve the peptides, phosphate and acetate aqueous buffers were prepared. None of the buffers contained hydrophobic solvents known to solubilize and stabilize &#x003b1;-helices (i.e. TFE or HFPI) or surfactants known to dissolve hydrophobic peptides (i.e. SDS). Henceforth, the A&#x003b2;<sub>17&#x02013;34</sub> peptide refers to the peptide flanked by two glutamates.</p></sec><sec><title>NMR sample preparation</title><p>To prepare a sample for NMR measurements, 1&#x000a0;mg of A&#x003b2;<sub>17&#x02013;34</sub> peptide was dissolved in 300&#x000a0;&#x003bc;l of 50&#x000a0;mM phosphate buffer (pH&#x000a0;7). To this solution, 15&#x000a0;&#x003bc;l of D<sub>2</sub>O (Sigma-Aldrich) and 1&#x000a0;&#x003bc;l of sodium azide (100&#x000a0;&#x003bc;M) (Sigma-Aldrich) were added to a final concentration of 50&#x000a0;mM PO<sub>4</sub>, 5% D<sub>2</sub>O and 0.3&#x000a0;&#x003bc;M NaN<sub>3</sub>. This NMR sample was pipetted into a Shigemi tube (Shigemi Corporation) and sealed with a plunger.</p></sec><sec><title>NMR experiments</title><p><sup>1</sup>H-NMR experiments were performed on a 600 MHz Bruker NMR spectrometer at 278 K. After calibration, 2D TOCSY and ROESY spectra were measured [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]) with 2048 and 1024 points in the F2 and F1 dimensions, respectively and 160 scans. The WATERGATE pulse sequence was used in order to suppress the water signal [<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>]. Mixing time for ROESY experiment was set to 400&#x000a0;ms for proper magnetization transfer. Spectral processing was carried out using Bruker TopSpin (version 3.2) software. Spectrum and chemical shift assignment were carried out using the sequential assignment technique developed by Kurt W&#x000fc;thrich [<xref rid="B13" ref-type="bibr">13</xref>].</p></sec><sec><title>Structure determination</title><p>Structure determination was performed using the Crystallography and NMR system (CNS, version1.3) software suite [<xref rid="B26" ref-type="bibr">26</xref>]. Structures were calculated with the distance geometry and simulated annealing protocols followed by energy minimization using distance and dihedral angle constraints. Dihedral angle constraints were derived from the <sup>3</sup>J<sub>HNH&#x003b1;</sub>-couplings measured in the TOCSY spectrum processed with 4096 points in the F2 dimension. Distance constrains were calculated from cross-peak height in the ROESY spectrum.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Peptide solubility</title><p>To solubilize A&#x003b2;, several approaches were taken. One approach was to add two arginines at the N- and C-termini. This addition increased the theoretical peptide pI from 4.37 (without arginines) to 11.54, but did not improve solubility in acetate and phosphate buffers at pH&#x000a0;1, 7 and 10. Another approach was to add two glutamic acids at the N- and C-termini. This addition decreased the theoretical peptide pI from 4.37 (without glutamates) to 3.83, and improved solubility drastically. The glutamic acid peptides were soluble in both 50&#x000a0;mM acetate and 50&#x000a0;mM phosphate buffers at pH&#x000a0;7 but not in water.</p></sec><sec><title>NMR sample preparation</title><p>NMR samples containing 1&#x000a0;mg of A&#x003b2;<sub>17&#x02013;34</sub> peptide dissolved in 300&#x000a0;&#x003bc;l of phosphate buffer displayed a pH of 7 (uncorrected for the isotope effect). The NMR samples did not show visible sedimentation or aggregation following 5&#x000a0;min centrifugation at 14000 Rev. per min at 278 K.</p></sec><sec><title>NMR measurements</title><p>The chemical shifts of all protons of the A&#x003b2;<sub>17&#x02013;34</sub> peptide were identified in the TOCSY spectrum using W&#x000fc;thrichs sequential assignment technique. <xref ref-type="fig" rid="F1">Figure 1</xref> shows the TOSCY spectrum of this peptide with its 18 amino acid systems. The four glutamic acid residues, two at the C-terminus and two at the N-terminus were not detected due to their high flexibility. The spectrum showed one system per amino acid and so was suggestive of a single conformation.</p><fig id="F1" position="float"><label>Figure 1</label><caption><title>Fingerprint region of TOCSY spectrum of A&#x003b2;<sub>17&#x02013;34</sub> peptide</title><p>Each line represents one amino acid system.</p></caption><graphic xlink:href="bsr2014-0094i001"/></fig><p>The ROESY spectrum (not shown) displayed intermediate range H&#x003b1;(<italic>i</italic>)/HN(<italic>i+</italic>4) cross-peaks between the following amino acid pairs: V18-E22, F20-V24, A21-G25, D23-N27, V24-K28, G25-G29, S26-A30, N27-I31, K28-I32, G29-G33 and A30&#x02013;L34 (summarized in <xref ref-type="fig" rid="F2">Figure 2</xref>). These cross-peaks were indicative of an &#x003b1;-helix conformation. Additional data supporting the &#x003b1;-helical structure include <sup>3</sup>J<sub>HNH&#x003b1;</sub>-couplings of residues F19, F20, D23, G25 and G33 with values of 6 Hz or less (<xref ref-type="fig" rid="F2">Figure 2</xref>). Also shown in <xref ref-type="fig" rid="F2">Figure 2</xref> is a summary of the H&#x003b1;(<italic>i</italic>), HN(<italic>i+</italic>1) connectivities used for the sequential assignment. Interestingly, no HN-H&#x003b1; cross-peak was observed between residues N27 and K28, suggesting a flexible random coil (or kink) in the helix around residues N27 and K28.</p><fig id="F2" position="float"><label>Figure 2</label><caption><title>Summary of NMR data used for the sequential assignment and secondary structure determination of A&#x003b2;<sub>17&#x02013;34</sub> peptide</title><p>The data were obtained from the ROESY spectrum recorded at 278 K and pH&#x000a0;7 with 400&#x000a0;ms mixing time. Line thickness indicates the relative cross-peak height of the sequential NOE connectivities.</p></caption><graphic xlink:href="bsr2014-0094i002"/></fig></sec><sec><title>NMR structure</title><p>The lowest energy NMR structures of the soluble A&#x003b2;<sub>17&#x02013;34</sub> peptide were found to adopt an &#x003b1;-helix conformation for most of the residues, with a break around S26, N27 and K28&#x000a0;in six out of ten ensemble structures. <xref ref-type="fig" rid="F3">Figure 3</xref> shows the average structure of the A&#x003b2;<sub>17&#x02013;34</sub> peptide. The &#x003b1;-helix spans residues 19&#x02013;26 and 28&#x02013;33 with a pronounced kink around residues S26, N27 and K28. Interestingly, the &#x003b1;-helix of residues 23&#x02013;26 and 28&#x02013;33 was not previously described. Please note that residues 17&#x02013;23 and 33&#x02013;34 did not adopt helical conformation probably due them being terminal residues. <xref ref-type="table" rid="T1">Table 1</xref> illustrates the statistical data of the final set of ten structures calculated using CNS. Distance constraints from the ROESY spectrum originated mainly from the fingerprint region. Torsion angle constraints were measured in the TOCSY spectrum with increased processing resolution and identified for residues F19, F20, D23, G25 and G33.</p><fig id="F3" position="float"><label>Figure 3</label><caption><title>Average NMR structure of the A&#x003b2;<sub>17&#x02013;34</sub> peptide</title><p>Shown is a ribbon diagram and stick representation of the A&#x003b2;<sub>17&#x02013;34</sub> structure. Notice the two &#x003b1;-helices formed by segments 19&#x02013;26 and 28&#x02013;33 with a break around residues S26, N27 and K28.</p></caption><graphic xlink:href="bsr2014-0094i003"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><title>NMR constrains and structural statistics for 10 A&#x003b2;<sub>17&#x02013;34</sub> peptide structures</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Measurements</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="1" colspan="1">NMR distance constrains</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Total constrains</td><td rowspan="1" colspan="1">86</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Medium range (|<italic>i</italic>&#x02013;<italic>j</italic>|&#x0003c;4)</td><td rowspan="1" colspan="1">11</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Torsion angle constraints (&#x003c6;)</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">Mean RMSD values</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Backbone atoms</td><td rowspan="1" colspan="1">1.48</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Backbone atoms of &#x003b1;-helix</td><td rowspan="1" colspan="1">0.28</td></tr></tbody></table></table-wrap><p><xref ref-type="table" rid="T2">Table 2</xref> shows a Chou&#x02013;Fasman secondary structure prediction of the A&#x003b2;<sub>1&#x02013;40</sub> peptide. [<xref rid="B27" ref-type="bibr">27</xref>]. The secondary structure was also predicted using more modern servers (NetsurfP [<xref rid="B28" ref-type="bibr">28</xref>], Jpred [<xref rid="B29" ref-type="bibr">29</xref>], I-TASSER [<xref rid="B30" ref-type="bibr">30</xref>]); however, the confidence level in these was not high. It is interesting to note that the A&#x003b2; peptide shows a high propensity for both &#x003b1; and &#x003b2; secondary structure. This tendency is an important hallmark in secondary structure conversion of the A&#x003b2; peptide. Our &#x003b1;-helical structure is in agreement with the Chou&#x02013;Fasman prediction and note that the kink observed around residues S26, and N27 coincides with residues G25 (&#x003b1;-helix propensity of 0.43), S26 (&#x003b1;-helix propensity of 0.57) and N27 (&#x003b1;-helix propensity of 0.76), which possess the lowest &#x003b1;-helix propensities of all amino acids, except proline [<xref rid="B31" ref-type="bibr">31</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><title>Chou&#x02013;Fasman secondary structure prediction of A&#x003b2;<sub>1&#x02013;40</sub></title></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"><graphic id="m10" xlink:href="bsr2014-0094i010"/></td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Several studies have shown that soluble A&#x003b2; and Alzheimer's disease are intertwined and that soluble A&#x003b2; peptide contributes to disease development and progression [<xref rid="B32" ref-type="bibr">32</xref>]. Nevertheless, many important details about soluble A&#x003b2; including its structure are missing, biased or contradicting.</p><p>Several studies found that A&#x003b2; peptides possess helical or random coil structures under non-physiological conditions. One NMR study found A&#x003b2;<sub>1&#x02013;40</sub> to adopt an 3<sub>10</sub>-helix in residues 13&#x02013;23&#x000a0;in aqueous environment (PDB ID 2LFM) [<xref rid="B19" ref-type="bibr">19</xref>]. Another NMR study found A&#x003b2;<sub>10&#x02013;35</sub> to adopt an &#x003b1;-helix in residues 13&#x02013;23 and 30&#x02013;35 inside SDS micelles [<xref rid="B20" ref-type="bibr">20</xref>]. However, at pH&#x000a0;7.3 A&#x003b2;<sub>10&#x02013;35</sub> is unstructured and adopts a compact random-coil conformation. In another study, the NMR structure of A&#x003b2;<sub>1&#x02013;42</sub> in a solution containing HFPI/H<sub>2</sub>O 30:70 adopts an &#x003b1;-helical conformation in residues 8&#x02013;25 and 28&#x02013;38 (PDB ID 1Z0Q) [<xref rid="B17" ref-type="bibr">17</xref>]. This finding is similar to ours; however we did not use solubilizing solvents capable of altering protein conformation.</p><p>In addition, A&#x003b2; was also found to adopt &#x003b2;-hairpin and &#x003b2;-sheet conformations. In one FTIR (Fourier-transform infrared) study, A&#x003b2; oligomers were found to adopt an antiparallel &#x003b2;-sheet structure [<xref rid="B33" ref-type="bibr">33</xref>]. Another study suggested that A&#x003b2;<sub>12&#x02013;42</sub> adopts an antiparallel &#x003b2;-sheet conformation with a turn at residues 25&#x02013;28 [<xref rid="B34" ref-type="bibr">34</xref>]. Finally, a third NMR study of A&#x003b2;<sub>1&#x02013;40</sub> in complex with a phage-display selected antibody, found that residues 17&#x02013;36 adopt a &#x003b2;-hairpin conformation with a turn composed of residues 23&#x02013;30 (PDB ID 2OTK) [<xref rid="B35" ref-type="bibr">35</xref>].</p><p>Our findings suggest that the &#x003b1;-helix is longer than previously observed [<xref rid="B19" ref-type="bibr">19</xref>] and it is in agreement with secondary structure predictions (<xref ref-type="table" rid="T2">Table 2</xref>). We did not observe the &#x003b1;-helix described in residues L17 and V18 (<xref ref-type="table" rid="T2">Table 2</xref>), probably because the peptide is truncated at residue 17. Also, we did not observe an &#x003b1;-helical conformation for residue L34 because the peptide is truncated here too.</p><sec><title>Interaction with nAChR (nicotinic acetylcholine receptor)</title><p>Since the first report of A&#x003b2; interacting with the nAChR was published [<xref rid="B36" ref-type="bibr">36</xref>] several studies attempted to determine the binding mode ([<xref rid="B37" ref-type="bibr">37</xref>] and references therein). Before binding the AChR (acetylcholine receptor), A&#x003b2; possesses a helical structure with a kink around residue K28. As was reported by us previously [<xref rid="B37" ref-type="bibr">37</xref>], K28 is an important anchor point for the amyloid in AChR. A kink around this residue would indeed facilitate anchoring and interaction between the A&#x003b2; and AChR. One could hypothesize that binding to AChR condemns it to undergo structural change form helix to &#x003b2;-sheet inside the binding pocket and leaves the peptide in &#x003b2;-sheet form, allowing it to form fibrils and plaques later. In this study, we show the intermediate soluble state of the A&#x003b2;, which could facilitate binding to the AChR.</p><p>Conformational transition</p><p>Interestingly, based on secondary structure propensities, the A&#x003b2; peptide shows a dual preference for &#x003b1;-helix and for &#x003b2;-sheet (<xref ref-type="table" rid="T2">Table 2</xref>). This double preference may be attributed to the environment, and A&#x003b2; embedded in membranes preferentially adopts an &#x003b1;-helical conformation. Contrarily, in aqueous environment the equilibrium between these states is pushed towards a &#x003b2;-sheet structure, and once this occurs, aggregation and sedimentation follow. In this study, we show the delicate intermediate state of the A&#x003b2; peptide solubilized by four glutamate residues. Using NMR, we show that A&#x003b2; peptide possesses a stable &#x003b1;-helical structure within residues F20&#x02013;S26 and K28&#x02013;G33 with a break around S26&#x02013;N27&#x02013;K28. The helical structure was not previously reported in an aqueous environment in the absence of organic solvents, and only a 3<sub>10</sub>-helix was observed. Another important finding of this research is a possible explanation regarding amyloids structural change from &#x003b1;-helix to &#x003b2;-sheet. Based on our structure, the existence of a kink in the middle of the peptide, which breaks it into two helices allows the peptide to undergo structural changes from &#x003b1;-helix to &#x003b2;-sheet once the two halves come close to one another (<xref ref-type="fig" rid="F4">Figure 4</xref>). Where it not for the solubilizing glutamate residues, then A&#x003b2;17&#x02013;34 would aggregate immediately upon leaving the membrane.</p><fig id="F4" position="float"><label>Figure 4</label><caption><title>Proposed model of A&#x003b2; structural changes</title><p>Shown from left to right is a proposed mechanism of A&#x003b2; transition from &#x003b1;-helix to &#x003b2;-sheet. Shown on the left is the &#x003b1;-helical solution structure of A&#x003b2;<sub>1&#x02013;42</sub> in an membrane-like environment (PDB ID 1IYT) [<xref rid="B15" ref-type="bibr">15</xref>]. Shown in the middle is our average NMR structure of the A&#x003b2;<sub>17&#x02013;34</sub> peptide (PDB ID 2MJ1). Shown on the right is the &#x003b2;-hairpin conformation of the A&#x003b2; peptide [<xref rid="B37" ref-type="bibr">37</xref>]).</p></caption><graphic xlink:href="bsr2014-0094i004"/></fig></sec><sec><title>Conclusions</title><p>This study sheds light on the soluble structure of A&#x003b2; and broadens our biomolecular understanding of Alzheimer's diseases. To the best of our knowledge, this study is the first to report an &#x003b1;-helix in A&#x003b2; in aqueous environment and at physiological conditions. The structure provides an important snapshot of the intermediate state between the pure &#x003b1;-helix and &#x003b2;-sheet conformations, and contributes to our understanding of the conformational transition of A&#x003b2; in Alzheimer's disease.</p></sec></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We would like to thank Dr Hugo E. Gottlieb for his generous help in conducting of the NMR experiments and Dr Jordan Chill for his assistance in sample preparations and data collection.</p></ack><sec><title>AUTHOR CONTRIBUTION</title><p>Abraham Samson conceived the study and wrote the paper. Genadiy Fonar measured the NMR spectra and calculated the structures.</p></sec><sec><title>FUNDING</title><p>This work was supported by the <funding-source id="gs1">Katz Foundation and Marie Curie CIG</funding-source> [grant number <award-id rid="gs1">322113</award-id>].</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzheimer</surname><given-names>A.</given-names></name><name><surname>Stelzmann</surname><given-names>R. A.</given-names></name><name><surname>Schnitzlein</surname><given-names>H. N.</given-names></name><name><surname>Murtagh</surname><given-names>F. R.</given-names></name></person-group><article-title>An English translation of Alzheimer's 1907 paper, &#x02018;Uber eine eigenartige Erkankung der Hirnrinde&#x02019;</article-title><source>Clin. Anat.</source><year>1995</year><volume>8</volume><fpage>429</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1002/ca.980080612</pub-id><?supplied-pmid 8713166?><pub-id pub-id-type="pmid">8713166</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>B. T.</given-names></name><name><surname>Marzloff</surname><given-names>K.</given-names></name><name><surname>Arriagada</surname><given-names>P. V.</given-names></name></person-group><article-title>The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>1993</year><volume>52</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1097/00005072-199311000-00006</pub-id><?supplied-pmid 8229078?><pub-id pub-id-type="pmid">8229078</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>C. L.</given-names></name><name><surname>Beyreuther</surname><given-names>K.</given-names></name></person-group><source>Neurodegenerative Diseases</source><year>2005</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Cambridge University Press</publisher-name></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruggink</surname><given-names>K. A.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Kuiperij</surname><given-names>H. B.</given-names></name><name><surname>Verbeek</surname><given-names>M. M.</given-names></name></person-group><article-title>Methods for analysis of amyloid-&#x003b2; aggregates</article-title><source>J. Alzheimers Dis.</source><year>2012</year><volume>28</volume><fpage>735</fpage><lpage>758</lpage><?supplied-pmid 22156047?><pub-id pub-id-type="pmid">22156047</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etienne</surname><given-names>M. A.</given-names></name><name><surname>Edwin</surname><given-names>N. J.</given-names></name><name><surname>Aucoin</surname><given-names>J. P.</given-names></name><name><surname>Russo</surname><given-names>P. S.</given-names></name><name><surname>McCarley</surname><given-names>R.&#x000a0;L.</given-names></name><name><surname>Hammer</surname><given-names>R. P.</given-names></name></person-group><article-title>Beta-amyloid protein aggregation</article-title><source>Methods Mol. Biol.</source><year>2007</year><volume>386</volume><fpage>203</fpage><lpage>225</lpage><?supplied-pmid 18604947?><pub-id pub-id-type="pmid">18604947</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunde</surname><given-names>M.</given-names></name><name><surname>Serpell</surname><given-names>L. C.</given-names></name><name><surname>Bartlam</surname><given-names>M.</given-names></name><name><surname>Fraser</surname><given-names>P. E.</given-names></name><name><surname>Pepys</surname><given-names>M. B.</given-names></name><name><surname>Blake</surname><given-names>C. C.</given-names></name></person-group><article-title>Common core structure of amyloid fibrils by synchrotron X-ray diffraction</article-title><source>J. Mol. Biol.</source><year>1997</year><volume>273</volume><fpage>729</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1997.1348</pub-id><?supplied-pmid 9356260?><pub-id pub-id-type="pmid">9356260</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000fc;hrs</surname><given-names>T.</given-names></name><name><surname>Ritter</surname><given-names>C.</given-names></name><name><surname>Adrian</surname><given-names>M.</given-names></name><name><surname>Riek-Loher</surname><given-names>D.</given-names></name><name><surname>Bohrmann</surname><given-names>B.</given-names></name><name><surname>D&#x000f6;beli</surname><given-names>H.</given-names></name><name><surname>Schubert</surname><given-names>D.</given-names></name><name><surname>Riek</surname><given-names>R.</given-names></name></person-group><article-title>3D structure of Alzheimer's amyloid-beta (1&#x02013;42) fibrils</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2005</year><volume>102</volume><fpage>17342</fpage><lpage>17347</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506723102</pub-id><?supplied-pmid 16293696?><pub-id pub-id-type="pmid">16293696</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheidt</surname><given-names>H. A.</given-names></name><name><surname>Huster</surname><given-names>D.</given-names></name><name><surname>Rothemund</surname><given-names>I.</given-names></name><name><surname>Morgado</surname><given-names>S.</given-names></name></person-group><article-title>Dynamics of amyloid fibrils revealed by solid-state NMR</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>2017</fpage><lpage>2021</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.308619</pub-id><?supplied-pmid 22130659?><pub-id pub-id-type="pmid">22130659</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>R. J.</given-names></name><name><surname>Wong</surname><given-names>P. C.</given-names></name></person-group><article-title>Amyloid precursor protein processing and Alzheimer's disease</article-title><source>Annu. Rev. Neurosci.</source><year>2011</year><volume>34</volume><fpage>185</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113613</pub-id><?supplied-pmid 21456963?><pub-id pub-id-type="pmid">21456963</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group><article-title>APP processing in Alzheimer's disease</article-title><source>Mol. Brain.</source><year>2011</year><volume>4</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/1756-6606-4-3</pub-id><?supplied-pmid 21214928?><pub-id pub-id-type="pmid">21214928</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epis</surname><given-names>R.</given-names></name></person-group><article-title>Alpha, beta-and gamma-secretases in Alzheimer's disease</article-title><source>Front. Biosci.</source><year>2012</year><volume>S4</volume><fpage>1126</fpage><pub-id pub-id-type="doi">10.2741/S322</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J.</given-names></name><name><surname>Allsop</surname><given-names>D.</given-names></name></person-group><article-title>Amyloid deposition as the central event in the aetiology of Alzheimer's disease</article-title><source>Trends Pharmacol. Sci.</source><year>1991</year><volume>12</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/0165-6147(91)90609-V</pub-id><?supplied-pmid 1763432?><pub-id pub-id-type="pmid">1763432</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wuthrich</surname><given-names>K.</given-names></name></person-group><source>NMR of Proteins and Nucleic Acids</source><year>1986</year><publisher-name>A Wiley-Interscience Publication</publisher-name></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Ursi</surname><given-names>A. M.</given-names></name><name><surname>Armenante</surname><given-names>M. R.</given-names></name><name><surname>Guerrini</surname><given-names>R.</given-names></name><name><surname>Salvadori</surname><given-names>S.</given-names></name><name><surname>Sorrentino</surname><given-names>G.</given-names></name><name><surname>Picone</surname><given-names>D.</given-names></name></person-group><article-title>Solution structure of amyloid &#x003b2;-peptide (25&#x02013;35) in different media</article-title><source>J. Med. Chem.</source><year>2002</year><volume>47</volume><fpage>4231</fpage><lpage>4238</lpage><pub-id pub-id-type="doi">10.1021/jm040773o</pub-id><pub-id pub-id-type="pmid">15293994</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crescenzi</surname><given-names>O.</given-names></name><name><surname>Tomaselli</surname><given-names>S.</given-names></name><name><surname>Guerrini</surname><given-names>R.</given-names></name><name><surname>Salvadori</surname><given-names>S.</given-names></name><name><surname>D&#x02019;Ursi</surname><given-names>A. M.</given-names></name><name><surname>Temussi</surname><given-names>P. A.</given-names></name><name><surname>Picone</surname><given-names>D.</given-names></name></person-group><article-title>Solution structure of the Alzheimer's amyloid beta-peptide (1&#x02013;42) in an apolar microenvironment. Similarity with a virus fusion domain</article-title><source>Eur. J. Biochem.</source><year>2002</year><volume>269</volume><fpage>5642</fpage><lpage>5648</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1033.2002.03271.x</pub-id><?supplied-pmid 12423364?><pub-id pub-id-type="pmid">12423364</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zagorski</surname><given-names>M. G.</given-names></name><name><surname>Colin</surname><given-names>J. B.</given-names></name></person-group><article-title>NMR Studies of Amyloid beta- peptides: proton assignments, secondary structure, and mechanism of an alpha-helix&#x02013;beta-sheet conversion for a homologous, 28-residue, N-terminal fragment</article-title><source>Biochemistry</source><year>1992</year><volume>31</volume><fpage>5621</fpage><lpage>5631</lpage><pub-id pub-id-type="doi">10.1021/bi00139a028</pub-id><?supplied-pmid 1610809?><pub-id pub-id-type="pmid">1610809</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>S.</given-names></name><name><surname>Esposito</surname><given-names>V.</given-names></name><name><surname>Vangone</surname><given-names>P.</given-names></name><name><surname>Nico</surname><given-names>A. J.</given-names></name><name><surname>Bonvin</surname><given-names>Alexandre M. J. J.</given-names></name><name><surname>Guerrini</surname><given-names>R.</given-names></name><name><surname>Tancredi</surname><given-names>T.</given-names></name><name><surname>Temussi</surname><given-names>P. A.</given-names></name><name><surname>Picone</surname><given-names>D.</given-names></name></person-group><article-title>The alpha-to-beta conformational transition of Alzheimer's Abeta-(1&#x02013;42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding</article-title><source>Chembiochem</source><year>2006</year><volume>7</volume><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1002/cbic.200500223</pub-id><?supplied-pmid 16444756?><pub-id pub-id-type="pmid">16444756</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraga</surname><given-names>A. S.</given-names></name><name><surname>Esteves</surname><given-names>A. C.</given-names></name><name><surname>Micaelo</surname><given-names>N.</given-names></name><name><surname>Cruz</surname><given-names>P. F.</given-names></name><name><surname>Brito</surname><given-names>R. M.</given-names></name><name><surname>Nutley</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>A.</given-names></name><name><surname>Barros</surname><given-names>M. M.</given-names></name><name><surname>Pires</surname><given-names>E. M.</given-names></name></person-group><article-title>Functional and conformational changes in the aspartic protease cardosin A induced by TFE</article-title><source>Int. J. Biol. Macromol.</source><year>2012</year><volume>50</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.12.018</pub-id><?supplied-pmid 22212471?><pub-id pub-id-type="pmid">22212471</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivekanandan</surname><given-names>S.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>A partially folded structure of amyloid-beta (1&#x02013;40) in an aqueous environment</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2011</year><volume>411</volume><fpage>312</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.06.133</pub-id><pub-id pub-id-type="pmid">21726530</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usachev</surname><given-names>K. S.</given-names></name><name><surname>Filippov</surname><given-names>A. V.</given-names></name><name><surname>Antzutkin</surname><given-names>O. N.</given-names></name><name><surname>Klochkov</surname><given-names>V. V.</given-names></name></person-group><article-title>Use of a combination of the RDC method and NOESY NMR spectroscopy to determine the structure of Alzheimer's amyloid Ab10-35 peptide in solution and in SDS micelles</article-title><source>Eur. Biophys. J.</source><year>2013</year><volume>42</volume><fpage>803</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1007/s00249-013-0928-7</pub-id><?supplied-pmid 24037178?><pub-id pub-id-type="pmid">24037178</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keeler</surname><given-names>J.</given-names></name><name><surname>Freeman</surname><given-names>R.</given-names></name><name><surname>Shaka</surname><given-names>A. J.</given-names></name></person-group><article-title>Evaluation of a new broadband decoupling sequence: WALTZ-16</article-title><source>J. Magn. Reson.</source><year>1983</year><volume>53</volume><fpage>313</fpage><lpage>340</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavanagh</surname><given-names>J.</given-names></name><name><surname>Rance</surname><given-names>M.</given-names></name></person-group><article-title>Sensitivity improvement in isotropic mixing (TOCSY) experiments</article-title><source>J. Magn. Reson.</source><year>1990</year><volume>88</volume><fpage>72</fpage><lpage>85</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Neuhaus</surname><given-names>D.</given-names></name><name><surname>Williamson</surname><given-names>M. P.</given-names></name></person-group><source>The nuclear Overhauser Effect in Structural and Conformational Analysis, 2<sup>nd</sup> Edition</source><year>1989</year><publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotto</surname><given-names>M.</given-names></name><name><surname>Saudek</surname><given-names>V.</given-names></name><name><surname>Sklen&#x000e1;r</surname><given-names>V.</given-names></name></person-group><article-title>Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions</article-title><source>J. Biomol. NMR</source><year>1992</year><volume>2</volume><fpage>661</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1007/BF02192855</pub-id><?supplied-pmid 1490109?><pub-id pub-id-type="pmid">1490109</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leppik</surname><given-names>R.</given-names></name><name><surname>Piotto</surname><given-names>M.</given-names></name><name><surname>Saudek</surname><given-names>V.</given-names></name><name><surname>Sklenar</surname><given-names>V.</given-names></name></person-group><article-title>Gradient-Tailored Water Suppression for 1H-15N HSQC experiments optimized to retain full sensitivity</article-title><source>J. Magn. Reson. Ser. A.</source><year>1993</year><volume>102</volume><fpage>241</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1006/jmra.1993.1098</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000fc;nger</surname><given-names>A. T.</given-names></name><name><surname>Adams</surname><given-names>P. D.</given-names></name><name><surname>Clore</surname><given-names>G. M.</given-names></name><name><surname>DeLano</surname><given-names>W. L.</given-names></name><name><surname>Gros</surname><given-names>P.</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name><name><surname>Jiang</surname><given-names>J. S.</given-names></name><name><surname>Kuszewski</surname><given-names>J.</given-names></name><name><surname>Nilges</surname><given-names>M.</given-names></name><name><surname>Pannu</surname><given-names>N. S.</given-names></name><etal/></person-group><article-title>Crystallography &#x00026; NMR system: a new software suite for macromolecular structure determination</article-title><source>Acta Crystallogr. D, Biol. Crystallogr.</source><year>1998</year><volume>54</volume><fpage>905</fpage><lpage>921</lpage><?supplied-pmid 9757107?><pub-id pub-id-type="pmid">9757107</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>P.</given-names></name><name><surname>Fasmanm</surname><given-names>G.</given-names></name></person-group><article-title>Prediction of protein conformation</article-title><source>Biochemistry</source><year>1974</year><volume>13</volume><fpage>222</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1021/bi00699a002</pub-id><?supplied-pmid 4358940?><pub-id pub-id-type="pmid">4358940</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>B.</given-names></name><name><surname>Petersen</surname><given-names>T. N.</given-names></name><name><surname>Andersen</surname><given-names>P.</given-names></name><name><surname>Nielsen</surname><given-names>M.</given-names></name><name><surname>Lundegaard</surname><given-names>C.</given-names></name></person-group><article-title>A generic method for assignment of reliability scores applied to solvent accessibility predictions</article-title><source>BMC Struct. Biol.</source><year>2009</year><volume>9</volume><fpage>51</fpage><pub-id pub-id-type="doi">10.1186/1472-6807-9-51</pub-id><?supplied-pmid 19646261?><pub-id pub-id-type="pmid">19646261</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>C.</given-names></name><name><surname>Barber</surname><given-names>J. D.</given-names></name><name><surname>Barton</surname><given-names>G. J.</given-names></name></person-group><article-title>The Jpred 3 secondary structure prediction server</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>W197</fpage><lpage>W201</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn238</pub-id><?supplied-pmid 18463136?><pub-id pub-id-type="pmid">18463136</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>I-TASSER server for protein 3D structure prediction</article-title><source>BMC Bioinformatics.</source><year>2008</year><volume>9</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-40</pub-id><?supplied-pmid 18215316?><pub-id pub-id-type="pmid">18215316</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Creighton</surname><given-names>T. E.</given-names></name></person-group><source>Proteins: Structures and Molecular Properties, 2<sup>nd</sup> Edition</source><year>1993</year><publisher-name>W.H Freeman</publisher-name></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M. P.</given-names></name><name><surname>LeVine</surname><given-names>H.</given-names></name></person-group><article-title>Alzheimer's disease and the amyloid-beta peptide</article-title><source>J. Alzheimers Dis.</source><year>2010</year><volume>19</volume><fpage>311</fpage><lpage>323</lpage><?supplied-pmid 20061647?><pub-id pub-id-type="pmid">20061647</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerf</surname><given-names>E.</given-names></name><name><surname>Sarroukh</surname><given-names>R.</given-names></name><name><surname>Tamamizu-Kato</surname><given-names>S.</given-names></name><name><surname>Breydo</surname><given-names>L.</given-names></name><name><surname>Derclaye</surname><given-names>S.</given-names></name><name><surname>Dufr&#x000ea;ne</surname><given-names>Y. F.</given-names></name><name><surname>Narayanaswami</surname><given-names>V.</given-names></name><name><surname>Goormaghtigh</surname><given-names>E.</given-names></name><name><surname>Ruysschaert</surname><given-names>J-M.</given-names></name><name><surname>Raussens</surname><given-names>V.</given-names></name></person-group><article-title>Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide</article-title><source>Biochem. J.</source><year>2009</year><volume>421</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1042/BJ20090379</pub-id><?supplied-pmid 19435461?><pub-id pub-id-type="pmid">19435461</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Darden</surname><given-names>T. A.</given-names></name><name><surname>Bartolotti</surname><given-names>L.</given-names></name><name><surname>Kominos</surname><given-names>D.</given-names></name><name><surname>Pedersen</surname><given-names>L. G.</given-names></name></person-group><article-title>An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments</article-title><source>Biophys. J.</source><year>1999</year><volume>76</volume><fpage>2871</fpage><lpage>2878</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(99)77442-4</pub-id><?supplied-pmid 10354415?><pub-id pub-id-type="pmid">10354415</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoyer</surname><given-names>W.</given-names></name><name><surname>Gr&#x000f6;nwall</surname><given-names>C.</given-names></name><name><surname>Jonsson</surname><given-names>A.</given-names></name><name><surname>St&#x000e5;hl</surname><given-names>S.</given-names></name><name><surname>H&#x000e4;rd</surname><given-names>T.</given-names></name></person-group><article-title>Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2008</year><volume>105</volume><fpage>5099</fpage><lpage>5104</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711731105</pub-id><?supplied-pmid 18375754?><pub-id pub-id-type="pmid">18375754</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H. Y.</given-names></name><name><surname>Lee</surname><given-names>D. H.</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>M. R.</given-names></name><name><surname>Peterson</surname><given-names>P. A.</given-names></name><name><surname>Shank</surname><given-names>R. P.</given-names></name><name><surname>Reitz</surname><given-names>A. B.</given-names></name></person-group><article-title>beta-Amyloid (1&#x02013;42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>5626</fpage><lpage>5632</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.8.5626</pub-id><?supplied-pmid 10681545?><pub-id pub-id-type="pmid">10681545</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maatuk</surname><given-names>N.</given-names></name><name><surname>Samson</surname><given-names>A. O.</given-names></name></person-group><article-title>Modeling the binding mechanism of Alzheimer's A&#x003b2;1&#x02013;A42 to nicotinic acetylcholine receptors based on similarity with snake &#x003b1;-neurotoxins</article-title><source>Neurotoxicology</source><year>2012</year><volume>34</volume><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2012.09.007</pub-id><?supplied-pmid 23022323?><pub-id pub-id-type="pmid">23022323</pub-id></element-citation></ref></ref-list></back></article>
